NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
NYSE:NUS - New York Stock Exchange, Inc. - US67018T1051 - Common Stock - Currency: USD
NUS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. NUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
NUS had positive earnings in 4 of the past 5 years.
NUS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NUS's Return On Assets of -2.77% is on the low side compared to the rest of the industry. NUS is outperformed by 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -5.11%, NUS is in line with its industry, outperforming 48.57% of the companies in the same industry.
NUS has a Return On Invested Capital of 3.49%. This is comparable to the rest of the industry: NUS outperforms 51.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NUS is significantly below the industry average of 13.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.77% | ||
| ROE | -5.11% | ||
| ROIC | 3.49% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
Looking at the Operating Margin, with a value of 2.98%, NUS is in line with its industry, outperforming 48.57% of the companies in the same industry.
NUS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 67.57%, NUS is in line with its industry, outperforming 57.14% of the companies in the same industry.
NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.98% | ||
| PM (TTM) | N/A | ||
| GM | 67.57% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUS is destroying value.
Compared to 1 year ago, NUS has more shares outstanding
Compared to 5 years ago, NUS has less shares outstanding
The debt/assets ratio for NUS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.91 indicates that NUS is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.91, NUS perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
NUS has a debt to FCF ratio of 3.62. This is a good value and a sign of high solvency as NUS would need 3.62 years to pay back of all of its debts.
NUS's Debt to FCF ratio of 3.62 is fine compared to the rest of the industry. NUS outperforms 80.00% of its industry peers.
NUS has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.29, NUS perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 3.62 | ||
| Altman-Z | 3.91 |
ROIC/WACC0.45
WACC7.69%
2.3 Liquidity
A Current Ratio of 2.02 indicates that NUS has no problem at all paying its short term obligations.
NUS's Current ratio of 2.02 is in line compared to the rest of the industry. NUS outperforms 54.29% of its industry peers.
A Quick Ratio of 1.29 indicates that NUS should not have too much problems paying its short term obligations.
The Quick ratio of NUS (1.29) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for NUS have decreased by -1.63% in the last year.
Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.85% on average per year.
The Revenue for NUS has decreased by -12.04% in the past year. This is quite bad
Measured over the past years, NUS shows a decrease in Revenue. The Revenue has been decreasing by -6.47% on average per year.
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
Revenue 1Y (TTM)-12.04%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
3.2 Future
NUS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.53% yearly.
NUS is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.06% yearly.
EPS Next Y17.87%
EPS Next 2Y-5.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.91%
Revenue Next 2Y-14.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.55, the valuation of NUS can be described as very reasonable.
94.29% of the companies in the same industry are more expensive than NUS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.87, NUS is valued rather cheaply.
The Price/Forward Earnings ratio is 15.24, which indicates a correct valuation of NUS.
77.14% of the companies in the same industry are more expensive than NUS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of NUS to the average of the S&P500 Index (35.34), we can say NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.55 | ||
| Fwd PE | 15.24 |
4.2 Price Multiples
NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 91.43% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 97.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.66 | ||
| EV/EBITDA | 5.02 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUS's earnings are expected to decrease with -5.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y-5.53%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.10%, NUS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.54, NUS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, NUS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
5.2 History
The dividend of NUS decreases each year by -30.50%.
NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of NUS are negative and hence is the payout ratio. NUS will probably not be able to sustain this dividend level.
The Dividend Rate of NUS has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-31%
EPS Next 2Y-5.53%
EPS Next 3YN/A
11.56
+0.12 (+1.05%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners75.35%
Inst Owner Change2.07%
Ins Owners2.16%
Ins Owner Change25.21%
Market Cap571.18M
Analysts45
Price Target7.65 (-33.82%)
Short Float %4.11%
Short Ratio3.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.1% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP-31%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)75.24%
Min EPS beat(2)73.83%
Max EPS beat(2)76.64%
EPS beat(4)3
Avg EPS beat(4)40.23%
Min EPS beat(4)-13.83%
Max EPS beat(4)76.64%
EPS beat(8)6
Avg EPS beat(8)31.67%
EPS beat(12)9
Avg EPS beat(12)24.2%
EPS beat(16)13
Avg EPS beat(16)20.75%
Revenue beat(2)2
Avg Revenue beat(2)1.84%
Min Revenue beat(2)1.17%
Max Revenue beat(2)2.51%
Revenue beat(4)3
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)2.51%
Revenue beat(8)4
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-2%
Revenue beat(16)6
Avg Revenue beat(16)-1.29%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.55 | ||
| Fwd PE | 15.24 | ||
| P/S | 0.34 | ||
| P/FCF | 8.66 | ||
| P/OCF | 5.25 | ||
| P/B | 0.76 | ||
| P/tB | 0.92 | ||
| EV/EBITDA | 5.02 |
EPS(TTM)1.21
EY10.47%
EPS(NY)0.76
Fwd EY6.56%
FCF(TTM)1.33
FCFY11.54%
OCF(TTM)2.2
OCFY19.05%
SpS33.99
BVpS15.26
TBVpS12.6
PEG (NY)0.53
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.77% | ||
| ROE | -5.11% | ||
| ROCE | 4.42% | ||
| ROIC | 3.49% | ||
| ROICexc | 4.31% | ||
| ROICexgc | 5.03% | ||
| OM | 2.98% | ||
| PM (TTM) | N/A | ||
| GM | 67.57% | ||
| FCFM | 3.93% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexcg growth 3Y-45.58%
ROICexcg growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score5
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 3.62 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 65.4% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.91 |
F-Score5
WACC7.69%
ROIC/WACC0.45
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y-41.01%
EPS 5Y-22.85%
EPS Q2Q%104.76%
EPS Next Y17.87%
EPS Next 2Y-5.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.04%
Revenue growth 3Y-13.71%
Revenue growth 5Y-6.47%
Sales Q2Q%-12.06%
Revenue Next Year-13.91%
Revenue Next 2Y-14.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.92%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y262.24%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y38.62%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%